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ABSTRACT
Background: For patients with deep brain stimulators
(DBS), local absorbed radiofrequency (RF) power is
unknown and is much higher than what the system
estimates. We developed a comprehensive, high-
quality brain magnetic resonance imaging (MRI)
protocol for DBS patients utilizing three-dimensional
(3D) magnetic resonance sequences at very low RF
power.
Methods: Six patients with DBS were imaged (10 ses-
sions) using a transmit/receive head coil at 1.5 Tesla
with modified 3D sequences within ultra-low specific
absorption rate (SAR) limits (0.1 W/kg) using T2, fast
fluid-attenuated inversion recovery (FLAIR) and T1-
weighted image contrast. Tissue signal and tissue con-
trast from the low-SAR images were subjectively and
objectively compared with routine clinical images of six
age-matched controls.
Results: Low-SAR images of DBS patients demon-
strated tissue contrast comparable to high-SAR images
and were of diagnostic quality except for slightly
reduced signal.
Conclusions: Although preliminary, we demonstrated
diagnostic quality brain MRI with optimized, volumetric
sequences in DBS patients within very conservative RF
safety guidelines offering a greater safety margin.
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The advantages of magnetic resonance imaging
(MRI) for mapping deep brain stimulation (DBS) lead
position1 or postoperative function2 have already been
demonstrated. However, local absorbed radiofrequency
(RF) power during routine MRI (specific absorption
rate [SAR]) at the electrodes is several times more than
that from whole-head SAR,3,4 creating significant risks
for such patients.5-7 DBS manufacturers7 have labeled
their devices as magnetic resonance (MR) conditional
by specifying a limit to head SAR of 0.1 W/kg at 1.5
Tesla (T) and RF exposure limited only to the head by
using a local (transmit/receive) head coil. The main rea-
son for heating concern is due to the “critical length”
of DBS leads (odd multiples of half wavelengths at 1.5
T or 3 T), producing unknown local heating8 that
varies with implantation techniques, including lead
geometry, patient posture in the MRI bore, chosen MR
sequences, and scanner hardware.
Given the increasing number of patients being treated
with such devices, a high-quality, low-SAR brain MRI
could be valuable, although it is not currently available.
For MRI of patients with DBS, some centers have cho-
sen to reduce the applied SAR by restricting imaging
volume or sequence types,9,10 whereas others have used
high-SAR MRI on DBS patients based on the low-
incidence track records.11-14 Three-dimensional (3D)
fast spin echo (FSE) sequences using reduced angle refo-
cusing pulses are promising and require one-third the
SAR of 2D FSE while preserving most of the tissue con-
trasts.15-18 In this work, we modified a recent work
that resulted in ultra-low-SAR 3D MRI for normal vol-
unteers19 and developed a comprehensive brain MRI
protocol that included T1, T2, and fluid-attenuated
inversion recovery (FLAIR) imaging at 10-fold to 30-
fold lower SAR for DBS recipients.
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Patients and Methods
Two authors (A.J.M. and R.F.B.) who are employees
of GE Healthcare were involved in providing the research
pulse sequences that were prospectively modified on
healthy volunteers and applied on DBS patients in com-
pliance with a retrospective institutional review board.
Patient Selection and Preimaging
Requirements
In total, 12 patients (6 women; age range, 45–81
years) were included in this study. Of these, six were
DBS recipients (4 with Parkinson’s disease, 2 with
essential tremor), and six were age-matched controls
without DBS. All patients were screened by earlier
MRI to exclude deep brain pathology. Prior to MRI,
the pulse generators were inactivated and set to bipo-
lar settings at 0 volts to minimize lead heating or
potential device re-activation. The indications for MRI
were assessment of targeting accuracy, postoperative
complications, or other neurologic conditions; whereas
the control patients were free of acute symptoms or
space-occupying lesions and underwent routine MRI
at high SAR (range, 2.2–3.0 W/kg) using more effi-
cient eight-channel head array coils.
Imaging Sequences and SAR Reduction Steps
The details of MR sequences are as follows (Table 1):
(1) 2D FSE T2 (control group, SAR 5 2.2 W/kg) and
3D FSE T2 (DBS group, SAR0.1 W/kg); (2) 2D
FLAIR (control group, SAR 5 1.5 W/kg) and 3D FLAIR
(DBS group, SAR0.1 W/kg); and (3) 3D inversion-
recovery spoiled gradient recalled-echo (IR-SPGR) (T1
identical for both groups: SAR 0.1 W/kg). 3D FSE T2
and 3D FLAIR sequences were modified from 3D-Cube
research FSE sequence (GE Healthcare, Milwaukee, WI)
by stretching refocusing RF pulse widths and reducing
refocusing flip angles and by linear-modulation view
ordering with skipping corners of k-space. The average
SAR for each sequence was verified at the research
interface before applying to patients, and the gradient
slew rate was maintained below 16 T per meter per
second.
Objective Signal-to-Noise Ratio, Relative
Tissue Contrast, and Statistical Tests
The noise regions of interest were drawn along the
frequency direction in air background for computing
the signal-to-noise ratio (SNR). Ten cerebral tissue
regions (frontal and parietal gray matter, adjacent
white matter, subthalamic nucleus, cerebral peduncle,
putamen, globus pallidus, ventricular fluid, and adja-
cent white matter) were selected from the right hemi-
sphere for computing the tissue SNR and contrast-to-
noise ratio (CNR) (CNR 5 [SNRa 2 SNRb]). A two-
tailed Wilcoxon rank-sum test was used to compare
tissue SNR as well as tissue CNR for the control and
DBS groups. Because SNR is proportional to pixel
area, the SNR for 3D T2 sections (256 3 256 matrix)
was scaled down by a factor of 1.56 to compare with
2D slices that had smaller pixels (resolution, 320 3
320). In addition, the scan time normalized SNR was
computed defined by SNR/(scan time).
Subjective Quality Assessment Relative to an
Implant-Free “Reference” Patient
One of the six implant-free control patients who
had a tissue SNR matching that of the control group
average was used as reference (assigned score 5 0) for
comparing image quality. Two senior neuroradiolo-
gists (D.B.H., R.A.B.) with over 25 years’ experience
subjectively evaluated the image appearance and signal
characteristics based on SNR, cerebrospinal fluid
intensity, gray/white matter contrast, and artifacts on
TABLE 1. Scan parameters for routine high-specific absorption rate (control group) and low- specific absorption rate
(implant group) MRI sequences at 1.5 Telsa


















































a 10 s/3 s/550 ms/256 3 224/5:30 min —/619.8 Excitation pulse angle, 12  0.1
aFor 3D IR-SPGR, the slice thickness was 1.1 mm; the radiofrequency coil was a body transmit/8-channel head receive device (for control patients) or a head
transmit/head receive (T/R) device (for deep brain stimulation patients); and the field of view was 22 3 18 cm2. For all FSE sequences, the slice thickness/gap
was 5/1.5 mm for 2D images and 5/0 mm for 3D images.
Abbreviations: TR, repetition time; TE, echo time; TI, the time between inversion and excitation pulses; SAR, specific absorption rate; 2D, two-dimensional;
FSE, fast spin echo; 3D, three-dimensional; FLAIR, fluid-attenuated inversion recovery; IR-SPGR, inversion-recovery spoiled gradient recalled-echo.
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a 5-point scale (22, 21, 0, 11, and 12, with 22
indicating the worst and 12 indicating the best).
Results
All low-SAR imaging studies were completed without
any complications. Figure 1 compares images from typ-
ical DBS patients with images from controls. From top
to bottom, the rows show 3D FLAIR, 3D T2-weighted,
and 3D T1-weighted images at ultra-low SAR (0.1
W/kg) (Fig. 1, left column) and images for a clinical
reference patient at routine clinical SAR (range, 2.2–3.0
W/kg) (Fig. 1, right column).
Objective Assessments
Compared with high-SAR 2D FLAIR, the scan time
normalized SNR from low-SAR 3D FLAIR was 47%
for gray matter, 45% for white matter, and 47% for
deep nuclei. Similarly, the scan time normalized SNR
for low-SAR 3D T2 was 67% for gray matter, 63%
for white matter, and 48% for deep nuclei compared
with high-SAR. The T1-weighted 3D IR-SPGR
sequence produced an SNR of 58% to 68% for DBS
compared with controls. The SNR reduction for all
three low-SAR sequences compared with high SAR was
statistically significant (P<0.05), whereas the tissue
contrasts were basically the same for both methods.
Subjective Assessment of Implant Group:
Quality Scores and Specific Features
The overall image-quality scores were as follows:
Both readers rated the low-SAR FLAIR and IR-SPGR
T1 sequences with overall scores close to that of the
reference control (DBS group, 20.3; reference control,
0), whereas the low-SAR T2 sequence produced a
slightly lower rating compared with the control (DBS
group, 20.8; reference control, 0). Overall, the con-
clusion was that the low-SAR images were adequately
diagnostic (score range, 21 to 11). Although a com-
parison of high and low SARs for various brain path-
ologies was beyond the scope of this work,
pathologies, including infection, infarcts, and subdural
hematoma, were observed with low SARs.
Discussion
Whole-head MRI heating when scanning within the
conditions of the DBS product label (0.1 W/kg)
should be 20-fold to 30-fold lower than heating from
routine MR sequences according to calorimetric prin-
ciple. In vitro testing that demonstrates an acceptable
temperature rise according to American Society for
Testing and Materials testing standards is approved by
the US Food and Drug Administration, although it
does not address the uncertainty in local heating by a
“critical length” implant like DBS, nor does it guaran-
tee safety for issues other than RF heating (personal
communication, Wolfgang Kainz, PhD, Center for
Devices and Radiological Health, US Food and Drug
Administration, Silver Spring, MD, USA).
Currently, a number of groups use low-power 3D
magnetization-prepared rapid gradient echo (MPRAGE)
for assessing DBS lead placements without directly iden-
tifying DBS targets, which can be identified in our
approach even at thick slices with T2 or FLAIR sequen-
ces. However, adopting a frame-based correction should
improve surgical efficacy further.20 Two-dimensional
FIG. 1. Low-specific absorption rate (SAR) images of deep brain stimu-
lation (DBS) are shown in the left column, and high-SAR images from
control patients are shown in the right column, including images from
(A) a DBS patient who had a recent cardiovascular accident (arrows
indicate the DBS leads; three-dimensional [3D] fluid-attenuated inversion
recovery [FLAIR] image; score, 20.5); (B) a representative control patient
(2D FLAIR; score, 0); (C) a DBS patient (arrows indicate bilateral sub-
stantia nigra pars compacta leads; 3D T2-weighted image; score, 21);
(D) another representative control patient (high-SAR; 2D T2-weighted
image; score, 0); (E) another DBS patient (arrows indicate the DBS
leads; 3D T1-weighted inversion-recovery spoiled gradient recalled-echo
[IR-SPGR] coronal reformat image; score, 0); and (F) a representative
control patient (3D T1-weighted IR-SPGR image; score, 0). Note that 3D
T1-weighted images for both DBS patients and control patients were
from identical sequences (SAR, 0.1 W/kg), except that, for the implant
group, we applied a local transmit/receive coil, which was approximately
60% as sensitive as the eight-channel multi-element coil with body coil
excitation that was used for the control group.
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imaging produces imperfect slice profiles that overlap
(cross-talk), whereas 3D sections are sharp with no
overlaps between adjacent slices and, thus, localize elec-
trodes better than 2D for identical slice thicknesses.
Our work was aimed to develop a full range of MR
sequences within a very conservative SAR guidance to
provide brain imaging for the growing population of
DBS patients and to compare the advantages and draw-
backs in diagnostic quality for this group compared
with routine MRI on implant-free patients at high
SAR. Note that, although absolute MR safety cannot
be guaranteed, based on calorimetric principles, a 20-
fold to 30-fold reduction in applied RF power com-
pared with a conventional high-SAR MRI, as demon-
strated here, would lead to a proportional decrease in
local tissue temperature and may be preferred when
MRI is absolutely needed for an implant patient. It
should be noted that the whole-head SAR is an approx-
imate estimate of the energy delivered to the tissue, and
there are additional concerns, including gradient-
induced effects or open circuits in case of a fractured
lead. At present, adverse events, including permanent
neurological injury with high-SAR, are rare,13 although
a recent report21 has expressed concern that MRI at
routine power might have caused neurologic deficits in
some cases that previously were attributed to surgery.
Low-SAR images had a lower SNR partly due to
lower sensitivity (65%) of the transmit/receive coil,22
whereas the tissue CNR matched well with that of the
control group. However, these results should be consid-
ered preliminary because of the small sample size. Cur-
rently, our quadrature coil does not allow parallel
imaging, which could have helped imaging speed and
further SAR reduction.
Conclusion
In this preliminary work, by conforming to the
strictest MR hardware and RF safety requirements, we
have developed a set of brain T1, FLAIR, and T2 MRI
sequences for DBS patients at very-low-SAR levels
(0.1 W/kg) that produce acceptable image quality
comparable to high-SAR sequences. With further in
vitro testing and regulatory approvals, this approach
has the potential for reducing, although not com-
pletely eliminating, RF heating risks for some of the
urgently desired MR procedures that are currently not
recommended by DBS manufacturers.
Acknowledgements: We thank Wolfgang Kainz, PhD (Center for
Devices and Radiological Health, US Food and Drug Administration) for
valuable discussions on implant safety and Aaron Grant, PhD for discus-
sions on image noise computations.
References
1. Wodarg F, Herzog J, Reese R, et al. Stimulation site within the
MRI-defined STN predicts postoperative motor outcome. Mov Dis-
ord 2012;27:874-879.
2. Boertien T, Zrinzo L, Kahan J, et al. Functional imaging of subtha-
lamic nucleus deep brain stimulation in Parkinson’s disease. Mov
Disord 2011;26:1835-1843.
3. Bottomley P, Roemer R. Homogeneous tissue model estimates of
SAR deposition in human NMR studies. Local elevations pre-
dicted in surface coil decoupling. Ann NY Acad Sci 1992;649:
144-159.
4. Collins CM, Liu W, Wang J, Gruetter R, Vaughan JT, Uqurbil K,
Smith MB. Temperature and SAR calculations for a human head
within volume and surface coils at 64 and 300 MHz. J Magn
Reson Imaging 2004;19:650-656.
5. Sharan A, Rezai AR, Nyenhuis JA, et al. MR safety in patients
with implanted deep brain stimulation systems (DBS). Acta Neuro-
chir Suppl 2003;87:141-145.
6. Rezai AR, Finelli D, Nyenhuis JA, et al. Neurostimulation systems
for deep brain stimulation: in vitro evaluation of magnetic reso-
nance imaging-related heating at 1.5 Tesla. J Magn Reson Imaging
2002;15:241-250.
7. Medtronic. MRI Guidelines for Medtronic Deep Brain Stimulation
Systems. Minneapolis, MN: Medtronic Inc.; 2007. Available at:
http://professional.medtronic.com/wcm/groups/mdtcom_sg/@mdt/@
neuro/documents/documents/dbs-2007-mri.pdf.
8. Kainz W. MR heating tests of MR critical implants. J Magn Reson
Imaging 2007;26:450-451.
9. Kovacs N, Nagy F, Kover F, et al. Implanted deep brain stimulator
and 1.0-Tesla magnetic resonance imaging. J Magn Reson Imaging
2006;24:1409-1412.
10. Huston OO, Watson RE, Bernstein MA, et al. Intraoperative mag-
netic resonance imaging findings during deep brain stimulation sur-
gery. J Neurosurg 2011;115:852-857.
11. Larson PS, Richardson RM, Starr PA, Martin AJ. Magnetic reso-
nance imaging of implanted deep brain stimulators: experience in a
large series. Stereotact Funct Neurosurg 2008;86:92-100.
12. Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS.
Subthalamic nucleus deep brain stimulator placement using high-
field interventional magnetic resonance imaging and skull mounted
aiming device: technique and application accuracy. J Neurosurg
2010;112:479-490.
13. Henderson J, Tkach J, Phillips M, Baker K, Shellock FG, Rezai
AR. Permanent neurological deficit related to magnetic resonance
imaging in a patient with implanted deep brain stimulation electro-
des for Parkinson’s disease: case report [serial online]. Neurosur-
gery 2005;57:E1063; discussion E1063.
14. Zrinzo L, Yoshida F, Hariz MI, Thornton J, Foltynie T, Yousry TA,
Limousin P. Clinical safety of brain magnetic resonance imaging
with implanted deep brain stimulation hardware: large case series
and review of the literature. World Neurosurg 2011;76:164-172.
15. Alsop D. The sensitivity of low flip angle RARE imaging. Magn
Reson Med 1997;37:176-184.
16. Hennig J, Weizel M, Scheffler K. Calculation of flip angles for
echo trains with predicted amplitudes with the extended phase
graph (EPG)-algorithm: principles and applications to hyperecho
and TRAPS sequences. Magn Reson Med 2004;51:68-80.
17. Mugler JP 3rd, Bao S, Mulkern RV, Guttmann CR, Robertson
RL, Jolesz FA, Brookeman JR. Optimized single-slab three-
dimensional spin-echo MR imaging of the brain. Radiology 2000;
216:891-899.
18. Busse RF, Brau AC, Vu A, et al. Effects of refocusing flip angle
modulation and view ordering in 3D fast spin echo. Magn Reson
Med 2008;60:640-649.
19. Sarkar S, Alsop DC, Madhuranthakam AJ, Busse RF, Robson PM,
Rofsky NM, Hackney DB. Brain MR imaging at ultra-low radio-
frequency power. Radiology 2011;259:550-557.
20. Holl E, Petersen EA, Foltynie T, Martinez-Torres I, Limousin P,
Hariz MI, Zrinzo L. Improving targeting in image-guided frame-
based deep brain stimulation. Neurosurgery 2010;67(2 suppl oper-
ative):437-447.
21. Zekaj E, Saleh C, Menghetti C, Servello D. Does magnetic reso-
nance imaging induce tissue damage due to DBS lead heating?
Acta Neurochir 2013;155:1677-1678.
22. Constantinides CD, Atalar E, McVeigh ER. Signal-to-noise meas-
urements in magnitude images from NMR phased arrays. Magn
Reson Med 1997;58:852-857.
U L T R A - L O W - P O W E R 3 D B R A I N M R I F O R D B S P A T I E N T S
Movement Disorders, Vol. 29, No. 4, 2014 549
